Cargando…
Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
Mitochondria are currently known as novel targets for treating cancer, especially for tumors displaying multidrug resistance (MDR). This present study aimed to develop a mitochondria-targeted delivery system by using triphenylphosphonium cation (TPP(+))-conjugated Brij 98 as the functional stabilize...
Autores principales: | Han, Xue, Su, Ruijuan, Huang, Xiuqing, Wang, Yingli, Kuang, Xiao, Zhou, Shuang, Liu, Hongzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032231/ https://www.ncbi.nlm.nih.gov/pubmed/32104484 http://dx.doi.org/10.1016/j.ajps.2018.06.006 |
Ejemplares similares
-
Synthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants
por: Jameson, Victoria J.A., et al.
Publicado: (2015) -
Effective magnetic hyperthermia induced by mitochondria‐targeted nanoparticles modified with triphenylphosphonium‐containing phospholipid polymers
por: Kaneko, Masahiro, et al.
Publicado: (2023) -
Mitochondria-targeted alginate/triphenylphosphonium-grafted-chitosan for treatment of hepatocellular carcinoma
por: Arafa, Kholoud K., et al.
Publicado: (2022) -
Efflux pump-mediated resistance to antifungal compounds can be prevented by conjugation with triphenylphosphonium cation
por: Chang, Wenqiang, et al.
Publicado: (2018) -
Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
por: Zinovkina, Ludmila A., et al.
Publicado: (2020)